Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial
Manuel Taboada, Nuria Rodríguez, Pablo Manuel Varela, María Teresa Rodríguez, Romina Abelleira, Amara González, Ana Casal, José Antonio Díaz Peromingo, Adriana Lama, María Jesús Domínguez, Carlos Rábade, Emilio Manuel Páez, Vanessa Riveiro, Hadrián Pernas, María del Carmen Beceiro, Valentín Caruezo, Alberto Naveira, Agustín Cariñena, Teresa Cabaleiro, Ana Estany-Gestal, Irene Zarra, Antonio Pose, Luis Valdés, Julián Álvarez-Escudero
Source: Eur Respir J, 60 (2) 2102518; 10.1183/13993003.02518-2021
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Manuel Taboada, Nuria Rodríguez, Pablo Manuel Varela, María Teresa Rodríguez, Romina Abelleira, Amara González, Ana Casal, José Antonio Díaz Peromingo, Adriana Lama, María Jesús Domínguez, Carlos Rábade, Emilio Manuel Páez, Vanessa Riveiro, Hadrián Pernas, María del Carmen Beceiro, Valentín Caruezo, Alberto Naveira, Agustín Cariñena, Teresa Cabaleiro, Ana Estany-Gestal, Irene Zarra, Antonio Pose, Luis Valdés, Julián Álvarez-Escudero. Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 pneumonia: an open-label, randomised clinical trial. Eur Respir J, 60 (2) 2102518; 10.1183/13993003.02518-2021
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|